You searched for "amblyopia"
A guide to utilising your time efficiently to develop clinical and procedural skills as an aspiring ophthalmologist
4 February 2025
| Shaswath Ganapathi
|
EYE - General
Ophthalmology often receives limited coverage in the undergraduate medical curriculum, and the availability of foundation programme jobs in this field is also restricted, reducing exposure to this field for aspiring ophthalmologists. Even if you’re not planning to specialise in ophthalmology,...
Comparison of vision screeners
The primary purpose of this study was to calibrate the various paediatric photoscreeners over a range of contact lens induced hyperopic and astigmatic anisometropia using the American Association of Paediatric Ophthalmology and Strabismus (AAPOS) criteria for anisometropic or axial astigmatism....Patients blinded by stem cells! How safe are they really?
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Patients blinded by stem cells! How safe are they really? Ever since the successful results following...Surgical treatment of high myopia
Although several excellent modalities are available for correcting high myopia, the surgical treatment of this condition remains one of the biggest challenges for refractive surgeons; this group of patients is often very dependent on contact lenses. If these patients become...Vision passport to be discussed at OSA June 10 meeting
The Digital Eye Care Alliance (DECA) meeting at the OSA Summer Belfry event on June 10, is opening its doors to non-OSA members who would like to know more about the rapid advances in digital eyecare.
HtrA1 enhances cell senescence
1 December 2013
| Graham Wallace
|
EYE - Vitreo-Retinal
A genetic basis for age-related macular degeneration (AMD) has been greatly advanced in recent years. The role of identified pathways such as complement factor H in AMD has been widely investigated. However, the effect of other gene variants identified by...
Stem cell therapy for Parkinson’s disease: researching for an effective cure
1 December 2015
| Romina Vuono
|
EYE - Neuro-ophthalmology
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...
Ranibizumab safety in pregnancy
1 December 2018
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Vascular endothelial growth factor (VEGF) plays a pivotal role during pregnancy, and systemic anti-VEGF administration during this period should thus be avoided. VEGF is expressed in multiple embryonic and foetal tissues during development, with the highest levels found in the...
How good does my vision have to be to drive this thing? Visual standards for various occupations
2 August 2022
| Myles Potter
|
EYE - General
We can all picture that moment in clinic: you are about to tell someone that they’re no longer legally able to drive, ready to deploy our ‘breaking bad news’ techniques. For some patients this may have been expected, or they...
Paediatric spectacle dispensing: more than a frame and lenses
1 April 2017
| Barry Duncan
|
EYE - General
It’s incredibly rewarding to fit a child’s first pair of spectacles and see their face light up; looking around to see the wider world for the first time. Sometimes it is so obvious that even the most reluctant parent will...
Eye Capacity: clinical need should drive ophthalmic service provision
1 February 2014
| Rod McNeil
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...
